These results indicates that, similar to C2 type, high RECK expression is also indicative of anti-tumor immune response and may associated with enrichment of IFN-γ-related signatures, which is a common trait of ICI-responsive malignancies 9. The gene discussed is RECK; the disease is neoplasm.